| 1. |
Wang WL, Lian H, Liang Y, et al. Molecular mechanisms of fibrosis in cholestatic liver diseases and regenerative medicine-based therapies[J]. Cells, 2024, 13(23): 1997.
|
| 2. |
Liu P, Guo L, Huang L, et al. Analysis of factors affecting the prognosis of neonatal cholestasis[J]. Int J Clin Exp Med, 2015, 8(5): 8005-8009.
|
| 3. |
Calkins KL, Venick RS, Devaskar SU. Complications associated with parenteral nutrition in the neonate[J]. Clin Perinatol, 2014, 41(2): 331-345.
|
| 4. |
Ma X, Zhou Y, Guo Y, et al. Predictive role of parenteral and enteral nutrition duration in parenteral nutrition-associated cholestasis among very preterm infants[J]. Front Pediatr, 2025, 13: 1651046.
|
| 5. |
Wang YS, Shen W, Yang Q, et al. Analysis of risk factors for parenteral nutrition-associated cholestasis in preterm infants: a multicenter observational study[J]. BMC Pediatr, 2023, 23(1): 250.
|
| 6. |
Alkharfy TM, Ba-Abbad R, Hadi A, et al. Total parenteral nutrition-associated cholestasis and risk factors in preterm infants[J]. Saudi J Gastroenterol, 2014, 20(5): 293-296.
|
| 7. |
Sharef SW, Al-Sinani S, Al-Naamani K, et al. Incidence and risk factors of parenteral nutrition-associated cholestasis in Omani neonates: single centre experience[J]. Sultan Qaboos Univ Med J, 2015, 15(2): e234-e240.
|
| 8. |
Madnawat H, Welu AL, Gilbert EJ, et al. Mechanisms of parenteral nutrition-associated liver and gut injury[J]. Nutr Clin Pract, 2020, 35(1): 63-71.
|
| 9. |
Naini BV, Lassman CR. Total parenteral nutrition therapy and liver injury: a histopathologic study with clinical correlation[J]. Hum Pathol, 2012, 43(6): 826-833.
|
| 10. |
Calder PC. The 2008 ESPEN Sir David Cuthbertson Lecture: Fatty acids and inflammation-from the membrane to the nucleus and from the laboratory bench to the clinic[J]. Clin Nutr, 2010, 29(1): 5-12.
|
| 11. |
El Kasmi KC, Anderson AL, Devereaux MW, et al. Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition-associated liver disease[J]. Sci Transl Med, 2013, 5(206): 206ra137.
|
| 12. |
Alwayn IP, Gura K, Nosé V, et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease[J]. Pediatr Res, 2005, 57(3): 445-452.
|
| 13. |
Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease[J]. Pediatrics, 2008, 121(3): e678-e686.
|
| 14. |
Diamond IR, Grant RC, Pencharz PB, et al. Preventing the progression of intestinal failure-associated liver disease in infants using a composite lipid emulsion: A pilot randomized controlled trial of SMOFlipid[J]. JPEN J Parenter Enteral Nutr, 2017, 41(5): 866-877.
|
| 15. |
Zou TT, Li JR, Zhu Y, et al. Fish oil-containing lipid emulsions prevention on parenteral nutrition-associated cholestasis in very low birth weight infants: a meta-analysis[J]. World J Pediatr, 2022, 18(7): 463-471.
|
| 16. |
Yang Q, Kong J, Bai RM, et al. Effects of mixed oil emulsion on short-term clinical outcomes in premature infants: A prospective, multicenter, randomized controlled trial[J]. Eur J Clin Nutr, 2023, 77(8): 823-832.
|
| 17. |
"實用新生兒學"第四版出版[J]. 中國實用兒科雜志, 2011, (6): 458.
|
| 18. |
劉津池, 劉暢, 華成舸. 隨機對照試驗偏倚風險評價工具RoB2(2019修訂版)解讀[J]. 中國循證醫學雜志, 2021, 21(6): 737-744.
|
| 19. |
Ozkan H, Koksal N, Dorum BA, et al. New-generation fish oil and olive oil lipid for prevention of oxidative damage in preterm infants: Single center clinical trial at university hospital in Turkey[J]. Pediatr Int, 2019, 61(4): 388-392.
|
| 20. |
谷葉蓮. SMOF對早產兒臨床結局及脂質過氧化影響研究[D]. 武漢: 華中科技大學, 2017.
|
| 21. |
楊欣, 陳北洋, 湛健萍. 多種油脂肪乳在極低出生體重早產兒中的應用效果[J]. 中國醫學創新, 2023, 20(36): 144-150.
|
| 22. |
盧柯穎, 付小麗, 盧芹芳. 早產兒腸外營養中應用多種油脂肪乳的臨床效果觀察[J]. 中國婦幼保健, 2023, 38(19): 3697-3700.
|
| 23. |
D'Ascenzo R, D'Egidio S, Angelini L, et al. Parenteral nutrition of preterm infants with a lipid emulsion containing 10% fish oil: effect on plasma lipids and long-chain polyunsaturated fatty acids[J]. J Pediatr, 2011, 159(1): 33-38. e1.
|
| 24. |
D'Ascenzo R, Savini S, Biagetti C, et al. Higher docosahexaenoic acid, lower arachidonic acid and reduced lipid tolerance with high doses of a lipid emulsion containing 15% fish oil: a randomized clinical trial[J]. Clin Nutr, 2014, 33(6): 1002-1009.
|
| 25. |
Najm S, L?fqvist C, Hellgren G, et al. Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: A randomized controlled trial[J]. Clin Nutr ESPEN, 2017, 20: 17-23.
|
| 26. |
Nehra D, Fallon EM, Potemkin AK, et al. A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial[J]. JPEN J Parenter Enteral Nutr, 2014, 38(6): 693-701.
|
| 27. |
Costa S, Cocca C, Barone G, et al. Growth of head circumference and body length in preterm infants receiving a multicomponent vs. a soybean-based lipid emulsion: a randomized controlled trial[J]. JPEN J Parenter Enteral Nutr, 2021, 45(1): 94-101.
|
| 28. |
Hsiao CC, Lin HC, Chang YJ, et al. Intravenous fish oil containing lipid emulsion attenuates inflammatory cytokines and the development of bronchopulmonary dysplasia in very premature infants: a double-blind, randomized controlled trial[J]. Clin Nutr, 2019, 38(3): 1045-1052.
|
| 29. |
Tejasatid W, Sapsaprang S, Tantiyavarong P, et al. Effectiveness of multicomponent lipid emulsion in preterm infants requiring parenteral nutrition: a two-center, double-blind randomized clinical trial[J]. J Med Associat Thailand, 2017, 100(9).
|
| 30. |
Uthaya S, Liu X, Babalis D, et al. Nutritional evaluation and optimisation in neonates: a randomized, double-blind controlled trial of amino acid regimen and intravenous lipid composition in preterm parenteral nutrition[J]. Am J Clin Nutr, 2016, 103(3): 871-877.
|
| 31. |
Pawlik D, Lauterbach R, Walczak M, et al. Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study[J]. JPEN J Parenter Enteral Nutr, 2014, 38(6): 711-716.
|
| 32. |
Savini S, D'Ascenzo R, Biagetti C, et al. The effect of 5 intravenous lipid emulsions on plasma phytosterols in preterm infants receiving parenteral nutrition: a randomized clinical trial[J]. Am J Clin Nutr, 2013, 98(2): 312-318.
|
| 33. |
Vlaardingerbroek H, Vermeulen MJ, Carnielli VP, et al. Growth and fatty acid profiles of VLBW infants receiving a multicomponent lipid emulsion from birth[J]. J Pediatr Gastroenterol Nutr, 2014, 58(4): 417-427.
|
| 34. |
Abrams SA, Ernst KD, Weitkamp JH, et al. Safety and efficacy of a composite lipid emulsion with fish oil in hospitalized neonates and infants requiring prolonged parenteral nutrition - A randomized, double-blind, multicenter, controlled trial[J]. J Nutr, 2024, 154(12): 3615-3625.
|
| 35. |
Ariyawangso U, Puttilerpong C, Ratanachu-ek S, et al. Short-term safety and efficacy of fish-oil emulsions on the prevention of parenteral nutrition-associated liver disease in surgical neonates: a randomized controlled trial[J]. Thai J Pharm Sci, 2014, 38(4).
|
| 36. |
Rayyan M, Devlieger H, Jochum F, et al. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants[J]. JPEN J Parenter Enteral Nutr, 2012, 36(1 Suppl): 81s-94s.
|
| 37. |
Beken S, Dilli D, Fettah ND, et al. The influence of fish-oil lipid emulsions on retinopathy of prematurity in very low birth weight infants: a randomized controlled trial[J]. Early Hum Dev, 2014, 90(1): 27-31.
|
| 38. |
Skouroliaakou M, Konstantinou D, Agakidis C, et al. Parenteral MCT/ω-3 polyunsaturated fatty acid-enriched intravenous fat emulsion is associated with cytokine and fatty acid profiles consistent with attenuated inflammatory response in preterm neonates: a randomized, double-blind clinical trial[J]. Nutr Clin Pract, 2016, 31(2): 235-244.
|
| 39. |
Yildizdas HY, Poyraz B, Atli G, et al. Effects of two different lipid emulsions on antioxidant status, lipid peroxidation and parenteral nutrition-related cholestasis in premature babies, a randomized-controlled study[J]. Pediatr Neonatol, 2019, 60(4): 359-367.
|
| 40. |
Pereira-da-Silva L, Nóbrega S, Rosa ML, et al. Parenteral nutrition-associated cholestasis and triglyceridemia in surgical term and near-term neonates: a pilot randomized controlled trial of two mixed intravenous lipid emulsions[J]. Clin Nutr ESPEN, 2017, 22: 7-12.
|
| 41. |
Repa A, Binder C, Thanhaeuser M, et al. A mixed lipid emulsion for prevention of parenteral nutrition associated cholestasis in extremely low birth weight infants: a randomized clinical trial[J]. J Pediatr, 2018, 194: 87-93.e1.
|
| 42. |
余彥亮, 陳雪雨, 范國清, 等. 左旋肉堿在超未成熟兒脂類及膽紅素代謝中的作用[J]. 臨床兒科雜志, 2022, 40(6): 431-435.
|
| 43. |
Lee HH, Jung JM, Nam SH, et al. Risk factor analysis of parenteral nutrition-associated cholestasis in extremely low birth weight infants[J]. Acta Paediatr, 2016, 105(7): e313-e319.
|
| 44. |
Navaratnarajah N, Girard G, Sant'Anna G, et al. The impact of a lipid injectable emulsion (SMOF) on conjugated bilirubin levels in children receiving prolonged parenteral nutrition: a large single center experience[J]. Clin Nutr ESPEN, 2022, 49: 289-294.
|
| 45. |
Kotiya P, Zhao X, Cheng P, et al. Fish oil- and soy oil-based lipid emulsions in neonatal parenteral nutrition: a systematic review and meta-analysis[J]. Eur J Clin Nutr, 2016, 70(10): 1106-1115.
|
| 46. |
Moin ZS, Evans HM, Buksh MJ, et al. Cholestasis and hepatic dysfunction associated with parenteral nutrition in a tertiary neonatal intensive care unit (NICU): a retrospective cohort study[J]. Intest Fail, 2024, 4: 100045.
|